Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $1.5 billion.

  • Agilon Health's Other Operating Expenses fell 76.54% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 billion, marking a year-over-year increase of 9701.82%. This contributed to the annual value of -$5.5 million for FY2022, which is N/A changed from last year.
  • Agilon Health's Other Operating Expenses amounted to $1.5 billion in Q3 2025, which was down 76.54% from $1.5 billion recorded in Q2 2025.
  • Over the past 5 years, Agilon Health's Other Operating Expenses peaked at $1.6 billion during Q4 2024, and registered a low of -$5.5 million during Q2 2022.
  • For the 5-year period, Agilon Health's Other Operating Expenses averaged around $931.9 million, with its median value being $982.4 million (2023).
  • Its Other Operating Expenses has fluctuated over the past 5 years, first surged by 8422.21% in 2021, then plummeted by 10113.91% in 2022.
  • Agilon Health's Other Operating Expenses (Quarter) stood at $151.0 million in 2021, then plummeted by 103.62% to -$5.5 million in 2022, then soared by 18100.05% to $982.4 million in 2023, then skyrocketed by 59.55% to $1.6 billion in 2024, then dropped by 3.89% to $1.5 billion in 2025.
  • Its Other Operating Expenses was $1.5 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.5 billion in Q1 2025.